Prana completes PBT2 dosing in IMAGINE Alzheimer’s Disease clinical trial December 12, 2013August 16, 2022
Alterity Therapeutics granted a new US patent targeting major neurodegenerative diseases including Alzheimer’s and Parkinson’s July 1, 2021August 16, 2022
Prana Details Data Showing that PBT2 Reduces Cognitive Impairment Caused by Tau Protein Accumulation July 17, 2013August 16, 2022